Skip to main content

Advertisement

Log in

Two retroviruses packaged in one cell line can combined inhibit the replication of HIV-1 in TZM-bl cells

  • Research Article
  • Published:
Virologica Sinica

Abstract

The cellular protein tetherin tethers the HIV-1 viral particles on the cellular membrane to inhibit the replication of HIV-1. However, the HIV-1 accessory protein Vpu counteracts the antiviral function of tetherin. In this study, two retroviral vector plasmids were constructed. One inhibited the vpu gene expression; the other one over-expressed the tetherin. Both retroviral vector plasmids could be packaged in the packaging cell line PT67 to obtain the corresponding retroviruses. The retroviral vector plasmids’ functions of tetherin over-expression or vpu-RNAi were detected at the cell level. Retroviral vector plasmids were transfected to PT67 cells at different ratios from 0T3V to 3T0V, and then mixed retroviruses were harvested. The antiviral functions of mixed retroviruses were detected in HIV-1 infected TZM-bl cells. The results showed that packaged mixed retroviruses could repress the replication of HIV-1 in TZM-bl cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Andrew A J, Miyagi E, Strebel K. 2010. Differential effects of human immunodeficiency virus type 1 vpu on the stability of bst-2/tetherin. J Virol, 85(6): 2611–2619.

    Article  PubMed  Google Scholar 

  2. Douglas J L, Viswanathan K, McCarroll M N, et al. 2009. Vpu directs the degradation of the human immunodeficiency virus restriction factor bst-2/tetherin via a tatrcp-dependent mechanism. J Virol, 83(16): 7931–7947.

    Google Scholar 

  3. Goto T, Kennel S J, Abe M, et al. 1994. A novel membrane antigen selectively expressed on terminally differentiated human b cells. Blood, 84(6): 1922–1930.

    PubMed  CAS  Google Scholar 

  4. Gupta R K, Mlcochova P, Pelchen-Matthews A, et al. 2009. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/bst-2/cd317 by intracellular sequestration. Proc Natl Acad Sci U S A, 106(49): 20889–20894.

    Article  PubMed  CAS  Google Scholar 

  5. Hauser H, Lopez L A, Yang S J, et al. 2010. Hiv-1 vpu and hiv-2 env counteract bst-2/tetherin by sequestration in a perinuclear compartment. Retrovirology, 7: 51.

    Article  PubMed  Google Scholar 

  6. Ishikawa J, Kaisho T, Tomizawa H, et al. 1995. Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, bst2, that may be involved in pre-b-cell growth. Genomics, 26(3): 527–534.

    Article  PubMed  CAS  Google Scholar 

  7. Klimkait T, Strebel K, Hoggan M D, et al. 1990. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol, 64(2): 621–629.

    PubMed  CAS  Google Scholar 

  8. Kong X, West J T, Zhang H, et al. 2008. The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses. J Virol, 82(23): 11609–11618.

    Article  PubMed  CAS  Google Scholar 

  9. Kupzig S, Korolchuk V, Rollason R, et al. 2003. Bst-2/hm1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic, 4(10): 694–709.

    Article  PubMed  CAS  Google Scholar 

  10. Le Tortorec A, Willey S, Neil S J. 2011. Antiviral inhibition of enveloped virus release by tetherin/bst-2: Action and counteraction. Viruses, 3(5): 520–540.

    Article  PubMed  Google Scholar 

  11. Liu C, Shi Y J, Xuan C h, et al. 2008. Establishment of an in vitro protein modification system with antiserum against ubiquitin-like modifier bisg15. Chin J Biochem Mol Biol, 24(1): 30–34. (in Chinese)

    Google Scholar 

  12. Liu C, Chang R, Yao X, et al. 2009. Isg15 expression in response to double-stranded rna or lps in cultured fetal bovine lung (fbl) cells. Vet Res Commun, 33(7): 723–733.

    Article  PubMed  CAS  Google Scholar 

  13. Malim M H, Emerman M. 2008. HIV-1 accessory proteins—ensuring viral survival in a hostile environment. Cell Host Microb, 3(6): 388–398.

    Article  CAS  Google Scholar 

  14. Miller A D, Chen F. 1996. Retrovirus packaging cells based on 10a1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol, 70(8): 5564–5571.

    PubMed  CAS  Google Scholar 

  15. Naito Y, Ui-Tei K, Nishikawa T, et al. 2006. Sivirus: Web-based antiviral sirna design software for highly divergent viral sequences. Nucleic Acids Res, 34(Web Server issue): W448–450.

    Article  PubMed  CAS  Google Scholar 

  16. Neil S J, Zang T, Bieniasz P D. 2008. Tetherin inhibits retrovirus release and is antagonized by hiv-1 vpu. Nature, 451(7177): 425–430.

    Article  PubMed  CAS  Google Scholar 

  17. Nguyen D H, Hildreth J E. 2000. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol, 74(7): 3264–3272.

    Article  PubMed  CAS  Google Scholar 

  18. Platt E J, Bilska M, Kozak S L, et al. 2009. Evidence that ecotropic murine leukemia virus contamination in tzm-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1. J Virol, 83(16): 8289–8292.

    Article  PubMed  CAS  Google Scholar 

  19. Reinke S O, Bayer M, Berger M, et al. 2011. Analysis of cell surface n-glycosylation of the human embryonic kidney 293t cell line. J Carbohydr Chem, 30(4–6): 218–232.

    Article  CAS  Google Scholar 

  20. Salmon P, Trono D. 2006. Design and production of human immunodeficiency virus-derived vectors, In: Cell biology: A laboratory handbook. Celis J E, ed., Third Edition: Elsevier Inc. Volume 1, pp 425–434.

  21. Skasko M, Wang Y, Tian Y, et al. 2011. HIV-1 vpu protein antagonizes innate restriction factor bst-2 via lipid-embedded helix-helix interactions. J Biol Chem, 287(1): 58–67.

    Article  PubMed  Google Scholar 

  22. Terwilliger E F, Cohen E A, Lu Y C, et al. 1989. Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci U S A, 86(13): 5163–5167.

    Article  PubMed  CAS  Google Scholar 

  23. Tokarev A, Skasko M, Fitzpatrick K, et al. 2009. Antiviral activity of the interferon-induced cellular protein bst-2/tetherin. AIDS Res Hum Retroviruses, 25(12): 1197–1210.

    Article  PubMed  CAS  Google Scholar 

  24. Van Damme N, Goff D, Katsura C, et al. 2008. The interferon-induced protein bst-2 restricts hiv-1 release and is downregulated from the cell surface by the viral vpu protein. Cell Host Microbe, 3(4): 245–252.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiaohong Kong or Chang Liu.

Additional information

Foundation items: National Natural Science Foundation of China (81101245, 30970162); The Fundamental Research Funds for the Central Universities (65011871); National Training Programs of Innovation for Undergraduates (111005505).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liang, Z., Guo, Z., Wang, X. et al. Two retroviruses packaged in one cell line can combined inhibit the replication of HIV-1 in TZM-bl cells. Virol. Sin. 27, 338–343 (2012). https://doi.org/10.1007/s12250-012-3263-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-012-3263-8

Keywords

Navigation